Personal information

No personal information available

Activities

Collapse all

Works (42)

Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.

2016-09 | Journal article
DOI: 10.1038/bmt.2016.224
PMID: 27643863
Contributors: Willasch AM; Salzmann-Manrique E; Krenn T; Duerken M; Faber J; Opper J; Kreyenberg H; Bager R; Huenecke S; Cappel C et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean section.

2016-07 | Journal article
DOI: 10.1016/j.earlhumdev.2016.06.004
PMID: 27351353
Contributors: Buxmann H; Reitter A; Bapistella S; Stürmer M; Königs C; Ackermann H; Louwen F; Bader P; Schlößer RL; Willasch AM
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy.

2016-04 | Journal article
DOI: 10.3324/haematol.2015.138016
PMID: 26768688
PMC: PMC5004389
Contributors: Rettinger E; Huenecke S; Bonig H; Merker M; Jarisch A; Soerensen J; Willasch A; Bug G; Schulz A; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

2015-04 | Journal article
DOI: 10.1200/jco.2014.58.4631
PMID: 25605857
Contributors: Bader P; Kreyenberg H; von Stackelberg A; Eckert C; Salzmann-Manrique E; Meisel R; Poetschger U; Stachel D; Schrappe M; Alten J et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia.

2015-03 | Journal article
DOI: 10.1158/1078-0432.ccr-14-1999
PMID: 25501127
Contributors: Steinbach D; Bader P; Willasch A; Bartholomae S; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Gruhn B
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.

2014 | Journal article
DOI: 10.3389/fped.2014.00075
PMID: 25101252
PMC: PMC4103003
Contributors: Rettinger E; Glatthaar A; Abhari BA; Oelsner S; Pfirrmann V; Huenecke S; Kuçi S; Kreyenberg H; Willasch AM; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow?

2014-12 | Journal article
DOI: 10.1016/j.bbmt.2014.07.030
PMID: 25087899
Contributors: Willasch AM; Kreyenberg H; Shayegi N; Rettinger E; Meyer V; Zabel M; Lang P; Kremens B; Meisel R; Strahm B et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.

2014-06 | Journal article
DOI: 10.1016/j.jcyt.2014.01.003
PMID: 24582456
Contributors: Rettinger E; Kreyenberg H; Merker M; Kuçi S; Willasch A; Bug G; Ullrich E; Wels WS; Bonig H; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation.

2013-08 | Journal article
DOI: 10.1038/bmt.2013.19
PMID: 23474803
Contributors: Rettinger E; Bonig H; Wehner S; Lucchini G; Willasch A; Jarisch A; Soerensen J; Esser R; Rossig C; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.

2012 | Journal article
DOI: 10.3389/fonc.2012.00032
PMID: 22655268
PMC: PMC3356002
Contributors: Rettinger E; Meyer V; Kreyenberg H; Volk A; Kuçi S; Willasch A; Koscielniak E; Fulda S; Wels WS; Boenig H et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Incidence of type 1 diabetes in childhood before and after the reunification of Germany--an analysis of epidemiological data, 1960-2006.

2012-09 | Journal article
DOI: 10.1055/s-0032-1309045
PMID: 22576256
Contributors: Ehehalt S; Neu A; Michaelis D; Heinke P; Willasch AM; Dietz K; DIARY-Group Baden-Wuerttemberg
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.

2012-09 | Journal article
DOI: 10.1038/leu.2012.76
PMID: 22430637
Contributors: Kramarzova K; Stuchly J; Willasch A; Gruhn B; Schwarz J; Cermak J; Machova-Polakova K; Fuchs O; Stary J; Trka J et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort-dependent increase within the next two decades in Germany.

2012-02 | Journal article
DOI: 10.1111/j.1399-5448.2012.00908.x
PMID: 21812877
Contributors: Ehehalt S; Dietz K; Willasch AM; Neu A; DIARY-Group Baden-Wuerttemberg
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.

2012-01 | Journal article
DOI: 10.3109/14653249.2011.613931
PMID: 21973023
Contributors: Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.

2011-11 | Journal article
DOI: 10.1182/blood-2011-04-348805
PMID: 21948300
Contributors: Rettinger E; Willasch AM; Kreyenberg H; Borkhardt A; Holter W; Kremens B; Strahm B; Woessmann W; Mauz-Koerholz C; Gruhn B et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells.

2011-09 | Journal article
DOI: 10.1016/j.beha.2011.04.005
PMID: 21925086
Contributors: Bader P; Soerensen J; Jarisch A; Ponstingl E; Krenn T; Faber J; Dürken M; Reinhardt H; Willasch A; Esser R et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats.

2011-09 | Journal article
DOI: 10.1038/leu.2011.118
PMID: 21681189
Contributors: van der Burg M; Kreyenberg H; Willasch A; Barendregt BH; Preuner S; Watzinger F; Lion T; Roosnek E; Harvey J; Alcoceba M et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.

2011-07 | Journal article
DOI: 10.1182/blood-2011-05-356451
PMID: 21799103
Contributors: Kreyenberg H; Jarisch A; Bayer C; Schuster B; Willasch A; Strahm B; Kremens B; Gruhn B; Schrauder A; Burdach S et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.

2010-10 | Journal article
DOI: 10.1016/j.bbmt.2010.07.001
PMID: 20637879
Contributors: Kröger N; Bacher U; Bader P; Böttcher S; Borowitz MJ; Dreger P; Khouri I; Olavarria E; Radich J; Stock W et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.

2010-10 | Journal article
DOI: 10.1200/jco.2010.29.3860
PMID: 20644087
Contributors: Hollink IH; van den Heuvel-Eibrink MM; Zimmermann M; Balgobind BV; Arentsen-Peters ST; Alders M; Willasch A; Kaspers GJ; Trka J; Baruchel A et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.

2010-09 | Journal article
DOI: 10.3324/haematol.2009.019885
PMID: 20378565
PMC: PMC2930961
Contributors: Kuçi S; Rettinger E; Voss B; Weber G; Stais M; Kreyenberg H; Willasch A; Kuçi Z; Koscielniak E; Klöss S et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.

2010-09 | Journal article
DOI: 10.1016/j.bbmt.2010.06.008
PMID: 20558311
Contributors: Kröger N; Bacher U; Bader P; Böttcher S; Borowitz MJ; Dreger P; Khouri I; Macapinlac HA; Macapintac H; Olavarria E et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy.

2010-03 | Journal article
DOI: 10.1532/lh96.09010
PMID: 20223744
Contributors: Rettinger E; Schumm M; Pfeiffer M; Kuçi S; Willasch A; Handgretinger R; Niethammer D; Lang P
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Epidemiological perspectives on type 1 diabetes in childhood and adolescence in germany: 20 years of the Baden-wurttemberg Diabetes Incidence Registry (DIARY).

2010-02 | Journal article
DOI: 10.2337/dc09-1503
PMID: 19903753
PMC: PMC2809277
Contributors: Ehehalt S; Dietz K; Willasch AM; Neu A; Baden-Württemberg Diabetes Incidence Registry (DIARY) Group
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

The graft-versus-tumor effect in pediatric malignancy.

2010-02 | Journal article
DOI: 10.1016/j.pcl.2009.12.002
PMID: 20307712
Contributors: Fry TJ; Willasch A; Bader P
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis.

2010-01 | Journal article
DOI: 10.1038/bmt.2009.89
PMID: 19421174
Contributors: Willasch A; Eing S; Weber G; Kuçi S; Schneider G; Soerensen J; Jarisch A; Rettinger E; Koehl U; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.

2009-09 | Journal article
DOI: 10.1038/leu.2009.70
PMID: 19357702
Contributors: Weber G; Karbach J; Kuçi S; Kreyenberg H; Willasch A; Koscielniak E; Tonn T; Klingebiel T; Wels WS; Jäger E et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.

2009-08 | Journal article
DOI: 10.1038/leu.2009.51
PMID: 19322206
Contributors: Willasch AM; Gruhn B; Coliva T; Kalinova M; Schneider G; Kreyenberg H; Steinbach D; Weber G; Hollink IH; Zwaan CM et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.

2009-07 | Journal article
DOI: 10.1038/leu.2009.72
PMID: 19357703
Contributors: Kreyenberg H; Eckert C; Yarkin Y; Reising M; Willasch A; Handgretinger R; Kremens B; von Stackelberg A; Henze G; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

2009-06 | Journal article
DOI: 10.1182/blood-2008-09-177949
PMID: 19171881
Contributors: Hollink IH; van den Heuvel-Eibrink MM; Zimmermann M; Balgobind BV; Arentsen-Peters ST; Alders M; Willasch A; Kaspers GJ; Trka J; Baruchel A et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Incidence of diabetes mellitus among children of Italian migrants substantiates the role of genetic factors in the pathogenesis of type 1 diabetes.

2009-05 | Journal article
DOI: 10.1007/s00431-008-0808-9
PMID: 18777043
Contributors: Ehehalt S; Popovic P; Muntoni S; Muntoni S; Willasch A; Hub R; Ranke MB; Neu A; DIARY Group Baden-Wuerttemberg
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

2009-01 | Journal article
DOI: 10.1200/jco.2008.17.6065
PMID: 19064980
Contributors: Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Monitoring of post-transplant remission of childhood malignancies: is there a standard?

2008-10 | Journal article
DOI: 10.1038/bmt.2008.280
PMID: 18978741
Contributors: Bader P; Willasch A; Klingebiel T
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Continuous rise in incidence of childhood Type 1 diabetes in Germany.

2008-06 | Journal article
DOI: 10.1111/j.1464-5491.2008.02450.x
PMID: 18544113
Contributors: Ehehalt S; Blumenstock G; Willasch AM; Hub R; Ranke MB; Neu A; DIARY-study Group Baden-Württemberg
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.

2007 | Journal article
DOI: 10.1532/lh96.07004
PMID: 17984038
Contributors: Willasch A; Schneider G; Reincke BS; Shayegi N; Kreyenberg H; Kuci S; Weber G; Van Der Reijden B; Niethammer D; Klingebiel T et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.

2006-06 | Journal article
PMID: 16769581
Contributors: Willasch A; Hoelle W; Kreyenberg H; Niethammer D; Handgretinger R; Lang P; Beck JF; Klingebiel T; Bader P
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.

2005-03 | Journal article
DOI: 10.1111/j.1365-2141.2004.05354.x
PMID: 15725087
Contributors: Bader P; Niemeyer C; Willasch A; Kreyenberg H; Strahm B; Kremens B; Gruhn B; Dilloo D; Vormoor J; Lang P et al.
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

How and when should we monitor chimerism after allogeneic stem cell transplantation?

2005-01 | Journal article
DOI: 10.1038/sj.bmt.1704715
PMID: 15502849
Contributors: Bader P; Niethammer D; Willasch A; Kreyenberg H; Klingebiel T
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Ketoacidosis at onset of type 1 diabetes mellitus in children--frequency and clinical presentation.

2003-06 | Journal article
DOI: 10.1034/j.1399-5448.2003.00007.x
PMID: 14655263
Contributors: Neu A; Willasch A; Ehehalt S; Hub R; Ranke MB; DIARY Group Baden-Wuerttemberg
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Varying clinical presentations at onset of type 1 diabetes mellitus in children--epidemiological evidence for different subtypes of the disease?

2001-12 | Journal article
DOI: 10.1034/j.1399-5448.2001.20402.x
PMID: 15016179
Contributors: Neu A; Ehehalt S; Willasch A; Kehrer M; Hub R; Ranke MB
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes.

2001-10 | Journal article
DOI: 10.1007/pl00002948
PMID: 11724411
Contributors: Neu A; Willasch A; Ehehalt S; Kehrer M; Hub R; Ranke MB
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0-14 years of age.

2001-04 | Journal article
DOI: 10.2337/diacare.24.4.785
PMID: 11315850
Contributors: Neu A; Ehehalt S; Willasch A; Kehrer M; Hub R; Ranke MB
Source: Self-asserted source
Andre Willasch via Europe PubMed Central

Peer review (4 reviews for 2 publications/grants)

Review activity for Bone marrow transplantation (3)
Review activity for Molecular and cellular pediatrics. (1)
How many people are using ORCID?